Literature DB >> 6287139

Assessment of alpha 2 adrenergic autoreceptor function in humans: effects of oral yohimbine.

D S Charney, G R Heninger, D E Sternberg.   

Abstract

Administration of three oral doses of yohimbine (10 mg, 15 mg, 20 mg) to eight healthy subjects resulted in significant increases in plasma free 3-methoxy-4-hydroxyphenylethyleneglycol (MHPG). The 15 mg and 20 mg yohimbine doses induced modest increases in systolic blood pressure and autonomic symptoms such as piloerection and rhinorrhea. Marked behavioral effects such as anxiety were not observed. These results indicate that determination of the plasma MHPG response to yohimbine may be of value in assessing alpha 2 adrenergic autoreceptor function in humans.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6287139     DOI: 10.1016/0024-3205(82)90444-1

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  20 in total

1.  Effects of yohimbine in obsessive compulsive disorder.

Authors:  S A Rasmussen; W K Goodman; S W Woods; G R Heninger; D S Charney
Journal:  Psychopharmacology (Berl)       Date:  1987       Impact factor: 4.530

2.  Yohimbine bioavailability in humans.

Authors:  S K Guthrie; M Hariharan; L J Grunhaus
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

3.  Effects of yohimbine and hydrocortisone on panic symptoms, autonomic responses, and attention to threat in healthy adults.

Authors:  Roma A Vasa; Daniel S Pine; Carrie L Masten; Meena Vythilingam; Carlos Collin; Dennis S Charney; Alexander Neumeister; Karin Mogg; Brendan P Bradley; Maggie Bruck; Christopher S Monk
Journal:  Psychopharmacology (Berl)       Date:  2009-03-06       Impact factor: 4.530

4.  Behavioural effects of the alpha 2-adrenoceptor antagonists idazoxan and yohimbine in rats: comparisons with amphetamine.

Authors:  D J Sanger
Journal:  Psychopharmacology (Berl)       Date:  1988       Impact factor: 4.530

5.  Discriminative stimulus effects of the alpha 2-adrenoceptor antagonist idazoxan.

Authors:  D J Sanger
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

6.  The effect of clonidine on plasma MHPG: evidence against tonic alpha 2-adrenoceptor control of noradrenergic function.

Authors:  D J Nutt; S G Molyneux
Journal:  Psychopharmacology (Berl)       Date:  1986       Impact factor: 4.530

7.  Evaluation of the alpha 2-adrenoceptor blocking properties of buspirone and ipsapirone in healthy subjects. Relationship with the plasma concentration of the common metabolite 1-(2-pyrimidinyl)-piperazine.

Authors:  I Berlin; S Chalon; C Payan; G Schöllnhammer; F Cesselin; O Varoquaux; A J Puech
Journal:  Br J Clin Pharmacol       Date:  1995-03       Impact factor: 4.335

8.  Noradrenergic response to acute ethanol administration in healthy subjects: comparison with intravenous yohimbine.

Authors:  C J McDougle; J H Krystal; L H Price; G R Heninger; D S Charney
Journal:  Psychopharmacology (Berl)       Date:  1995-03       Impact factor: 4.530

9.  Dose-response relationship for oral idazoxan effects in healthy human subjects: comparison with oral yohimbine.

Authors:  J H Krystal; C J McDougle; S W Woods; L H Price; G R Heninger; D S Charney
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

10.  The pharmacokinetics of yohimbine in man.

Authors:  J A Owen; S L Nakatsu; J Fenemore; M Condra; D H Surridge; A Morales
Journal:  Eur J Clin Pharmacol       Date:  1987       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.